Adding chemotherapy to hormone therapy added 14 months to patients’ lives in study
Chemotherapy at the start of hormone therapy can extend the lives of men with prostate cancer that has spread beyond the gland, a new study finds. Over nearly 29 months of follow-up, men with advanced prostate cancer who received the combination therapy lived almost 14 months longer than men who received only hormone therapy (58 months versus 44 months), researchers said. Read the article.
Adding chemotherapy to hormone therapy added 14 months to patients’ lives in study Read More »